Abstract #2903

MOLLI versus SMART1 mapping for quantitative brain tumor DCE MRI on a 3T GE 750w: Initial experience

Greg O Cron^1,2,3, Michael A Gulak⁴, Nicholas Majtenyi⁵, Ian G Cameron^1,3,5, and Thanh B Nguyen^1,3

¹Medical Imaging, The Ottawa Hospital, Ottawa, ON, Canada, ²Ottawa Hospital Research Institute, Ottawa, ON, Canada, ³Radiology, University of Ottawa, Ottawa, ON, Canada, ⁴Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, ⁵Physics, Carleton University, Ottawa, ON, Canada

In radiotherapy of high-grade gliomas, radiation changes (RC) are common. RC and tumor recurrence (TR) may both demonstrate progressive Gd contrast enhancement on follow-up, rendering conventional MRI unhelpful. DCE MRI, however, shows promise for distinguishing RC from TR. We set up a new protocol for brain tumor DCE-MRI on a 3T GE 750w. This protocol involved bookend T1 mapping performed with both MOLLI and SMART1. We found that both T1 mapping sequences gave similar results. Although patient numbers are low at this time, the technique appears promising for distinguishing radiation changes from tumor recurrence.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.